RNA, U6 small nuclear 1085, pseudogene (RNU6-1085P)

RNU6-1085P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA genes encode a highly conserved small RNA component of the spliceosome, essential for pre-mRNA splicing in eukaryotic cells[1][3]. However, RNU6-1085P is a pseudogene: a genomic sequence that originated from the U6 parent gene but contains mutations or truncations that prevent it from producing a functional U6 RNA or participating in spliceosome activity[5]. Pseudogenes like RNU6-1085P are often created through reverse transcription and retrotransposition, frequently mediated by LINE-1 (L1) elements[5]. While most pseudogenes were long considered nonfunctional "genomic fossils," recent research suggests some can play indirect regulatory roles (such as acting as microRNA sponges or influencing chromatin organization)[4]. However, there is no evidence that RNU6-1085P specifically has such a function; it is best classified as nonfunctional for medical or drug discovery purposes. No drugs, disease associations, or clinical relevance have been reported for RNU6-1085P, and it should not be considered a target in drug discovery. - See also: U6 snRNA pseudogenes are abundant in the human genome and are used in genomics to study retrotransposition and genome evolution, but not as clinical or therapeutic targets[5].

Other names

RNU6-1085PU6-1085PU6 snRNA pseudogene 1085